Tsukuba, Japan

Takayuki Nakagawa

USPTO Granted Patents = 4 



Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Takayuki Nakagawa

Introduction

Takayuki Nakagawa is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for cancer treatment. With a total of 4 patents to his name, Nakagawa's work is recognized for its potential impact on cancer therapies.

Latest Patents

Among his latest patents is a therapeutic agent for breast cancer. This innovative application discloses a therapeutic agent comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof. Another notable patent is an antitumor agent that utilizes compounds with kinase inhibitory effects in combination. This antitumor agent demonstrates an excellent effect compared to individual use, showcasing its efficacy against various cancer types.

Career Highlights

Takayuki Nakagawa is currently employed at Eisai R&D Management Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic strategies that can significantly improve patient outcomes in cancer treatment.

Collaborations

Throughout his career, Nakagawa has collaborated with notable colleagues, including Hiroshi Obaishi and Tomohiro Matsushima. These collaborations have fostered a productive environment for research and development, leading to advancements in cancer therapies.

Conclusion

Takayuki Nakagawa's contributions to cancer research and treatment exemplify the importance of innovation in pharmaceuticals. His patents reflect a commitment to improving therapeutic options for patients, and his work continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…